Newton Fund

Genomelink operates a digital genetic analysis platform that lets individuals upload their raw DNA data to generate reports on traits, wellness, ancestry, and nutrition. The service translates genomic information into user-friendly interpretations for personal exploration and genetic self-knowledge. It emphasizes data privacy by upholding user ownership of data, implementing ISO-certified security, and offering options to delete data. The company positions itself as a consumer-focused provider of accessible, detailed genomic insights, supporting informed health and lifestyle decisions while ensuring control and transparency over personal genetic information.

Rellevate, LLC is a financial services company based in Stamford, Connecticut, founded in 2019. It specializes in providing digital banking services that empower consumers to access, move, and manage their money seamlessly. Rellevate offers a range of products, including digital accounts with interest, a Visa debit card, and services such as Pay Any-Day, bill payment, and money transfer facilities. Primarily targeting employers, Rellevate aims to enhance employee retention, reduce turnover, and increase satisfaction and loyalty by enabling employees to take greater control over their financial well-being through its innovative offerings.

Bambu is a prominent digital wealth technology provider that focuses on developing and marketing digital wealth solutions for financial institutions. Founded in 2016 and headquartered in Singapore, the company offers its products under the brand names Intelligent Advisor, White-Label Robo, and Portfolio Builder. Bambu's cloud-based platform utilizes proprietary algorithms and machine learning tools to simplify saving and investing for clients. The company caters to various sectors, including banking, family offices, insurance, and asset management, serving over 20 financial institutions globally. In addition to its Singapore headquarters, Bambu has a subsidiary in the United Kingdom and the United States, along with representatives in the EMEA region. By leveraging advanced technology, Bambu enables its clients to provide personalized investment advice and create tailored portfolios for their customers.

Mesentech Inc. is a regenerative medicine company based in Vancouver, Canada, focused on developing innovative therapies for bone-related diseases. Established in 2013, the company specializes in a prodrug platform that delivers therapeutics selectively to bone, addressing challenges associated with conventional drug delivery methods. Mesentech's lead product, MES1007, is a bone-targeted prodrug of a prostaglandin mimetic that aims to reverse bone loss associated with conditions such as osteoporosis and Duchenne muscular dystrophy. The company's proprietary technology enhances the delivery of small-molecule and biological drugs to the bone's surface and interior, allowing for more effective treatment while minimizing side effects. This approach is particularly significant given the inherent difficulty in accessing bone tissue due to its hard surface and low porosity. Mesentech's focus on selective drug delivery not only aims to improve treatment efficacy but also hopes to accelerate bone healing and address complications associated with low bone density disorders.

WRM Software specializes in developing business productivity applications aimed at enhancing operational efficiency. Their key offerings include Storm Manager and Ops Manager, which are designed for ease of use and facilitate seamless integration between field and office operations. These applications ensure that all team members have access to the most current information at all times. WRM Software supports emergency response operations and field service management, providing businesses with essential tools to manage their resources effectively.

Founded in 2019, Brelyon specializes in manufacturing immersive display solutions. Its flagship product is a headset-free virtual monitor, offering an alternative to multi-monitor setups and VR headsets for office, gaming, and teleoperations.

Avails Medical, Inc., founded in 2013 and headquartered in Menlo Park, California, is an in vitro diagnostics company focused on addressing antibiotic resistance and healthcare-associated infections. The company's flagship product, eQuant, is a compact instrument that uses a cuvette with an integrated electrical sensor to detect infections rapidly and accurately from any bodily fluid. This technology provides real-time information on the most effective antibiotics at the point of prescription, significantly reducing time-to-treatment from days to minutes. By enabling diagnostic-guided therapy at the point-of-care, Avails Medical aims to transform the diagnostics market and combat the global health threat of antibiotic resistance.

Founded in 2018 by scientists from Yale University's Strittmatter Lab, ProteoWise specializes in developing innovative proteomic technology. Its flagship product is a 3D nanoscale protein capturing material that simplifies western blot analysis while providing high information content and throughput at a low cost.

SkyCool Systems Inc. is a San Francisco-based company that specializes in developing and manufacturing innovative cooling and refrigeration systems. Incorporated in 2016, the company focuses on delivering sustainable and energy-efficient cooling solutions aimed at reducing energy costs and carbon footprints. SkyCool Systems has pioneered the technology of radiative cooling, utilizing specially designed optical films that reflect sunlight and emit thermal radiation effectively. This allows their rooftop cooling panels to operate passively during the hottest hours of the day. The panels can be integrated with existing air conditioning and refrigeration systems, serving as an add-on or, in some cases, replacing traditional air condensing units. Through this approach, SkyCool Systems is contributing to a transition towards a cleaner and more sustainable future.

ProbiusDx Inc. is a manufacturer of portable diagnostic devices that utilize an electronic sensing platform to analyze multiple target proteins in real time. Founded in 2015 and headquartered in El Cerrito, California, the company focuses on providing diagnostic technology for the detection and monitoring of blood concentrations. This innovative approach allows healthcare professionals to make informed decisions regarding appropriate therapies for patients in critical care settings. ProbiusDx aims to enhance patient outcomes through its advanced diagnostic solutions.

MoQuality Inc. is a technology company founded in 2014 and headquartered in Atlanta, Georgia, that specializes in artificial intelligence-driven mobile testing solutions. The company focuses on enhancing the application development process by providing tools that allow developer teams to create, run, and maintain tests efficiently. MoQuality's flagship product, Barista, offers a scriptless test automation experience, leveraging AI to generate user-centric test scenarios for mobile applications. This platform enables developers to conduct comprehensive end-to-end UI testing across various devices and operating systems, ensuring that applications are thoroughly vetted before reaching consumers. By streamlining the testing process, MoQuality aims to help developers deliver higher-quality apps and improve overall user experiences.

Blumio, Inc. is a healthcare technology company based in San Francisco, California, founded in 2014. The company specializes in the development of a non-invasive radio frequency wearable sensor designed to measure blood pressure and other cardiovascular diagnostics. Unlike traditional methods that rely on inflatable cuffs, Blumio's sensor utilizes radar technology to detect and analyze the pressure waves traveling through blood vessels, enabling continuous and accurate monitoring of blood pressure throughout daily activities. This innovative approach allows users to track their cardiovascular health in real-time, providing insights that traditional devices cannot offer. By focusing on the dynamic nature of blood pressure and its variations based on activity, Blumio aims to enhance the way individuals monitor their vitals and improve overall health and wellness.

Motion Gestures is a Canadian startup based in Waterloo, founded in 2016, that specializes in machine learning-based gesture recognition software. The company focuses on enabling the rapid development and deployment of gesture-enabled interfaces for various systems, devices, and applications. Its software supports advanced 2D and 3D gestures using motion, touch, and vision sensors and can be deployed across cloud, gateway/hub, and embedded platforms. Motion Gestures offers developers free licenses to its cloud SDK, allowing them to create and test any gesture using their smartphones without the need for programming or data input.

PointCloud is a technology company that specializes in developing a 3D imaging platform on a chip, focusing on high-performance 4D imaging solutions. The company's innovative technology employs big data analytics and machine learning to analyze 3D point clouds, which enhances applications in augmented reality, robotics, and autonomous mobility. By leveraging these advanced capabilities, PointCloud aims to provide users with a clearer and more interactive understanding of their environments, facilitating significant advancements in various technological fields.

InsightFinder is a technology company that provides AI-powered observability and IT management solutions. It offers unsupervised machine‑learning based anomaly detection, root-cause analysis, and incident prediction to automatically identify, diagnose, and remediate issues across applications and infrastructure. The platform delivers real-time log analysis, metric intelligence, and alert management to reduce noise and alert fatigue while helping IT teams prevent outages and optimize performance. Its solutions are designed for enterprise-scale environments, enabling proactive maintenance for homegrown and third‑party applications and services. Headquartered in Brooklyn, New York, InsightFinder serves organizations seeking predictive analytics and automated troubleshooting to improve reliability and efficiency in complex IT ecosystems.

Founded in 2014 by Stanford University Biodesign Fellows collaborating with leading urologists, Zenflow develops a novel spring device to alleviate permanent benign prostatic hyperplasia (BPH) symptoms in men. Its minimally invasive solution preserves natural anatomy and improves patient experience.

Founded in 2020 with headquarters in Boston, Massachusetts, Aperio Systems specializes in cybersecurity solutions for industrial control systems. Its proprietary technology detects real-time data manipulation to safeguard systems and enable prompt remediation without disrupting operations.

MODit 3D Inc., established in 2016 and based in San Rafael, California, specializes in automated quality control solutions for the manufacturing sector. The company offers advanced 3D scanning systems that are easily deployable across various production environments. By integrating these systems with a cloud platform, MODit enhances operational efficiency, increases production yields, and facilitates improved communication regarding quality standards throughout the supply chain.

C2Sense develops chemiresistive gas sensors for food and agriculture applications, monitoring fruit ripeness and meat/fish/poultry freshness. Its sensors detect ethylene and biogenic amines at low concentrations, helping reduce waste throughout the supply chain.

Vivid Vision is a technology company that develops a virtual reality based therapy platform for vision disorders such as amblyopia (lazy eye) and strabismus. The core offering, the Vivid Vision software suite, provides interactive tests for eye dominance, suppression, angle of deviation, and contrast sensitivity, and allows clinicians to monitor and control a patient's experience from a touchscreen interface. The system measures eye muscle imbalance and delivers different images to each eye to assess binocular vision and treat amblyopia, enabling ophthalmologists to treat strabismus and convergence disorders effectively. The platform is designed for use in eye clinics, primarily in North America. The company was founded in 2014 in San Francisco and later renamed from Apollo VR to Vivid Vision in 2015.